[Action of E39 in malignant pharyngolaryngeal tumors].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001388:Aziridines; D006801:Humans; D007822:Laryngeal Neoplasms; D007830:Larynx; D009369:Neoplasms; D010610:Pharyngeal Neoplasms; D010614:Pharynx
D000970:Antineoplastic Agents; D001388:Aziridines; C026480:inproquone
CYTOTOXIC DRUGS/therapeutic use; LARYNX/neoplasms; PHARYNX/neoplasms
L'action de l'E 39 dans les tumeurs malignes pharyngolaryngées.